Advertisement

Das akute Koronarsyndrom Non-Q-Wave-Infarkt/instabile Angina

  • Elisabeth von der Lohe
Chapter
  • 16 Downloads

Zusammenfassung

Das akute Koronarsyndrom weist ein weites Spektrum auf: auf der einen Seite findet sich die akute myokardiale Ischämie ohne EKG-Veränderungen und ohne enzymatischen Nachweis einer myokardialen Nekrose, auf der anderen Seite der transrnurale Infarkt mit Ausbildung von Q-Zacken trotz Fehlen von ST-Streckenhebungen im akuten Infarktstadium und initialer Klassifikation als Non-Q-Wave-Infarkt (2- 15% aller Patienten). Der Non-Q-Wave-Infarkt ist häufiger bei der Frau (25%) als beim Mann (16%) anzutreffen. Der Thrombus beim Non-QWave- Infarkt ist in der Regel thrombozytenreich (Q-Wave-Infarkt: erythrozten- und fibrinreich) und korreliert mit der Tatsache, dass Frauen eine höhere Thrombozytenaggregabilität aufweisen als Männer. Dies spielt für die Wirksamkeit der Therapie eine wichtige Rolle.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Anonymous (1994) Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC 11 prospective randomised multicentre study. Fragmin and Fast Revascularisation during InStability in Coronary artery disease Investigators. Lancet 354(9180):708–715Google Scholar
  2. Ambrose JA, Dangas G (2000) Unstable angina: Current concepts of pathogenesis and treatment. Arch Int Med 160:25–37CrossRefGoogle Scholar
  3. Antman EM, McCabe CH, Gurfinkel EP et al. (1999) Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Circulation 100:1593–1601PubMedCrossRefGoogle Scholar
  4. Bhatt DL, Topoi EJ (2000) Current Role of Glycoprotein IIb/IIIa Inhibitors in Acute Coronary Syndromes. JAMA 284(12):1549–1558PubMedCrossRefGoogle Scholar
  5. Boden WE, O’Rourke RA, Crawford MH et al. (1998) Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. Veterans Affairs Non-Q-Wave Infarction Strategies in Hospital (VANQWISH) Trial Investigators. N Engl J Med 338(25):1785–1792PubMedCrossRefGoogle Scholar
  6. Boersmann E, Akkerhuis Km, Theroux P et al. (1999) Platelet glycoprotein IIb/Iia receptor inhibition in non-ST-elevation acute coronary syndromes:early benefit during medical treatment only, with additional protection during percutaneous coronary intervention. Circulation 100:2045–2048Google Scholar
  7. Braunwald E, Jones RH, Mark DB et al. (1994) Diagnosing and managing unstable angina. Circulation 90:613–622PubMedCrossRefGoogle Scholar
  8. Cairns JA, Gent M, Singer J et al. (1985) Aspirin, sulfinpyrazone, or both in unstable angina: results of a Canadian multicenter trial. N Engl. J Med. 313:1369–1375PubMedCrossRefGoogle Scholar
  9. Califf R (1999) Glycoprotein IIb/IIIa blockade and thrombolytics: Early lessons from the Speed and GUSTO IV trials. Am Heart J 138(1, Part 2):S12–S15PubMedCrossRefGoogle Scholar
  10. Cannon CP, Weintraub WS, Demopoulos LA et al. (1998) Invasive vs. conservative strategies in unstable angina and non-Q-wave myocardial infarction following treatment with tirofiban: rationale and study design of the international TACTICS-TIMI 18 Trial. Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy. Thrombolysis in Myocardial Infarction. Am J of Cardiol 82(6):731–736CrossRefGoogle Scholar
  11. Fragmin during Instability in Coronary Artery Disease (Frisc) Study Group (1996) Low-molecular-weight-heparin during instability in coronary artery disease. Lancet 347:561–568Google Scholar
  12. Gurfinkel EP, Manos EJ, Mejail RI et al. (1995) Low molecular weight heparin vs. regular heparin or aspirin in the treatment of unstable angina and silent ischemia. J Am Coll Cardiol 2: 313–318CrossRefGoogle Scholar
  13. Klein W, Buchwald A, Hillis WS et al. (1997) Fragmin in unstable angina pectoris or in non-Q-wave acute myocardial infarction (the FRIC study). Fragmin in Unstable Coronary Artery Disease.Am J Cardiol 80(5A):30E–34EPubMedCrossRefGoogle Scholar
  14. Libby P (1995) Molecular bases of the acute coronary syndromes. Circulation 91:2844–2850PubMedCrossRefGoogle Scholar
  15. Neri Serneri GG, Modesti PA, Gensini GF et al. (1995) Randomised comparison of subcutaneous heparin, intravenous heparin, and aspirin in unstable angina. Lancet 345:1201–1204PubMedCrossRefGoogle Scholar
  16. Stone PH, Thompson B, Anderson HV et al. (1996) Influence of race, sex, and age on management of unstable angina and non-Q-wave myocardial infarction. The TIMI III registry. JAMA 275:1104–1112PubMedCrossRefGoogle Scholar
  17. The PARAGON Investigators (1998) International, randomized, controlled trial of lamifiban (a platelet glycoprotein IIb/lIla inhibitor), heparin, or both in unstable angina. Circulation 97:2386–2395CrossRefGoogle Scholar
  18. The PRISM Investigators (1998) A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina. N Engl J Med 338: 1498–1505CrossRefGoogle Scholar
  19. The PRISM-PLUS Investigators (1998) Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave mocardial infarction. N Engl J Med 338:1488–1497CrossRefGoogle Scholar
  20. The PURSUIT Investigators (1998) Inhibition of platelet glycoprotein IIb/ IIIa with eptifibatide in patients with acute coronary syndromes. N Engl J Med 339:436–443CrossRefGoogle Scholar
  21. Theroux P, Ouimet H, McCans J et al. (1988) Aspirin, heparin, or both to treat acute unstable angina. N Engl J Med 319:1105–1111PubMedCrossRefGoogle Scholar
  22. Theroux P, Waters D, Qui S et al. (1993) Aspirin vs. heparin to prevent myocardial infarction during the acute phase of unstable angina. Circulation 88:2045–2048PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2002

Authors and Affiliations

  • Elisabeth von der Lohe
    • 1
  1. 1.Wishard Health ServicesKrannert Institute of CardiologyIndianapolisUSA

Personalised recommendations